Magnus Financial Group LLC Bristol Myers Squibb CO Transaction History

Magnus Financial Group LLC

$1.06 Billion
Q2 2025

A detailed history of Magnus Financial Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Magnus Financial Group LLC holds 10,240 shares of BMY stock, worth $476,672. This represents 0.04% of its overall portfolio holdings.

Number of Shares

10,240

Previous 7,537 35.86%

Holding current value

$476,672

Previous $459,000 3.27%

% of portfolio

0.04%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	BUY	$44.12 - $59.6 $119,256 - $161,098	2,703 Added 35.86%	10,240 $474,000
Q1 2025 Apr 11, 2025	SELL	$53.9 - $63.11 $14,930 - $17,481	-277 Reduced 3.54%	7,537 $459,000
Q4 2024 Jan 17, 2025	BUY	$51.92 - $59.94 $89,665 - $103,516	1,727 Added 28.37%	7,814 $441,000
Q3 2024 Oct 15, 2024	BUY	$39.66 - $51.75 $241,410 - $315,002	6,087 New	6,087 $315,000
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $863 - $979	18 Added 0.33%	5,476 $296,000
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $45,668 - $54,494	-942 Reduced 14.72%	5,458 $280,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $27,208 - $30,423	-470 Reduced 6.84%	6,400 $371,000
Q2 2023 Jul 19, 2023	BUY	$63.71 - $70.74 $30,963 - $34,379	486 Added 7.61%	6,870 $439,000
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $45,274 - $51,351	689 Added 12.1%	6,384 $442,000
Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $48,552 - $57,492	709 Added 14.22%	5,695 $409,000
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $14 - $8,836	115 Added 2.36%	4,986 $354,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $69,061 - $76,060	951 Added 24.26%	4,871 $375,000
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $36,826 - $44,158	599 Added 18.04%	3,920 $286,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $178,105 - $207,628	3,321 New	3,321 $207,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $196,030 - $229,624	-3,313 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $3,157 - $3,438	51 Added 1.56%	3,313 $221,000
Q1 2021 May 05, 2021	SELL	$59.34 - $66.74 $394,907 - $444,154	-6,655 Reduced 67.11%	3,262 $206,000
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $77,487 - $87,807	-1,342 Reduced 11.92%	9,917 $615,000
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $80,402 - $89,096	-1,400 Reduced 11.06%	11,259 $679,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $62,165 - $72,678	-1,134 Reduced 8.22%	12,659 $744,000
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $240,166 - $349,017	5,176 Added 60.07%	13,793 $769,000
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $178,435 - $232,752	3,626 Added 72.65%	8,617 $553,000
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $10,136 - $12,018	-237 Reduced 4.53%	4,991 $253,000
Q2 2019 Aug 05, 2019	BUY	$44.62 - $49.34 $233,273 - $257,949	5,228 New	5,228 $237,000
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $190,000 - $226,551	-4,211 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $205,328 - $266,261	4,211 New	4,211 $219,000

Others Institutions Holding BMY

# of Institutions

2,665

Shares Held

1.6B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.

Account

Magnus Financial Group LLC Bristol Myers Squibb CO Transaction History